These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression. Steinacker P; Verde F; Fang L; Feneberg E; Oeckl P; Roeber S; Anderl-Straub S; Danek A; Diehl-Schmid J; Fassbender K; Fliessbach K; Foerstl H; Giese A; Jahn H; Kassubek J; Kornhuber J; Landwehrmeyer GB; Lauer M; Pinkhardt EH; Prudlo J; Rosenbohm A; Schneider A; Schroeter ML; Tumani H; von Arnim CAF; Weishaupt J; Weydt P; Ludolph AC; Yilmazer Hanke D; Otto M; J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):239-247. PubMed ID: 29142138 [TBL] [Abstract][Full Text] [Related]
30. VEGF levels in CSF and serum in mild ALS patients. Gao L; Zhou S; Cai H; Gong Z; Zang D J Neurol Sci; 2014 Nov; 346(1-2):216-20. PubMed ID: 25204587 [TBL] [Abstract][Full Text] [Related]
31. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients. Zheng Y; Gao L; Wang D; Zang D Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118 [TBL] [Abstract][Full Text] [Related]
32. RANTES levels are elevated in serum and cerebrospinal fluid in patients with amyotrophic lateral sclerosis. Rentzos M; Nikolaou C; Rombos A; Boufidou F; Zoga M; Dimitrakopoulos A; Tsoutsou A; Vassilopoulos D Amyotroph Lateral Scler; 2007 Oct; 8(5):283-7. PubMed ID: 17852013 [TBL] [Abstract][Full Text] [Related]
33. Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis? Gille B; De Schaepdryver M; Dedeene L; Goossens J; Claeys KG; Van Den Bosch L; Tournoy J; Van Damme P; Poesen K J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1338-1346. PubMed ID: 31175169 [TBL] [Abstract][Full Text] [Related]
34. Reduced angiotensin II levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Kawajiri M; Mogi M; Higaki N; Tateishi T; Ohyagi Y; Horiuchi M; Miki T; Kira JI Acta Neurol Scand; 2009 May; 119(5):341-4. PubMed ID: 18798831 [TBL] [Abstract][Full Text] [Related]
35. Amino acids acting as transmitters in amyotrophic lateral sclerosis (ALS). Niebroj-Dobosz I; Janik P Acta Neurol Scand; 1999 Jul; 100(1):6-11. PubMed ID: 10416506 [TBL] [Abstract][Full Text] [Related]
36. Role of platelet derived growth factor (PDGF) in reverting neuronal nuclear and soma size alterations in NSC-34 cells exposed to cerebrospinal fluid from amyotrophic lateral sclerosis patients. Chen YY; Liu XW; Gong TX; Zhang ZY; Liu YE; Zhang YB; Xiang LB; Xia H Clin Neurol Neurosurg; 2014 May; 120():1-5. PubMed ID: 24731566 [TBL] [Abstract][Full Text] [Related]
37. Aberrant Levels of Cystatin C in Amyotrophic Lateral Sclerosis: a Systematic Review and Meta Analysis. Zhu Y; Yang M; Li F; Li M; Xu Z; Yang F; Liu Y; Chen W; Zhang Y; Xu R Int J Biol Sci; 2018; 14(9):1041-1053. PubMed ID: 29989057 [TBL] [Abstract][Full Text] [Related]